Methanol extract of Biophytum sensitivum alters the cytokine profile and inhibits iNOS and COX-2 expression in LPS/Con a stimulated macrophages

Drug and Chemical Toxicology

Volumn 31, Issue 1, 2008, Pages 175-188

  Guruvayoorappan, Chandrasekharan ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Bioassay; Biophytum sensitivum; Concanavalin A; COX; Lipopolysaccharide; Nitric oxide; Proinflammatory cytokines

Indexed keywords

ALCOHOL; BIOPHYTUM SENSITIVUM EXTRACT; CONCANAVALIN A; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOASSAY; BIOPHYTUM SENSITIVUM; CELL STIMULATION; CELL STRAIN L 929; CENTRIFUGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPRESSION; GENE EXPRESSION; INFLAMMATION; LUNG FIBROBLAST; MACROPHAGE; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANGIOSPERMS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CONCANAVALIN A; CYCLOOXYGENASE 2; CYTOKINES; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; METHANOL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; RNA, MESSENGER; SOLVENTS; TUMOR NECROSIS FACTOR-ALPHA;

BIOPHYTUM SENSITIVUM;

EID: 37649024146     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540701688915     Document Type: Article

References (40)

1. Asai, K., Kato, H., Kimura, S., Mukai, S., Kawahito, Y., Sano, H., Kondo, M., Akaogi, K., Hirose, K. (1996). Induction of gene expression of nitric oxide by immunomodulating drugs in the RAW 265.7 murine macrophage cell line. Cancer Immunol. Immun. 42:275-279.
2. Bonta, I. L., Ben-Efralm, S. (1993). Involvement of inflammatory mediators in macrophage antitumor activity. J. Leukoc. Biol. 54:613-626.
3. De Nardin, E. (2001). The role of inflammatory and immunological mediators in periodontis and cardiovascular disease. Ann. Periodontol. 6:30-40.
4. Engelberts, I., Von Asmuth, E. J. U., Van Der Linden, C. J., Buurman, W. A. (1991). The interrelation between TNF-α, IL-6, and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymphokine Cytokine Res. 10:127-131.
5. Feinstein, D. L., Galea, E., Roberts, S., Berquist, H., Wang, H., Reis, D. J. (1994). Induction of nitric oxide synthase in rat C6 glioma cells. J. Neurochem. 62:315-321.
6. Gidday, J. M., Park, T. S., Shah, A. R., Gonzales, E. R. (1998). Modulation of basal and post-ischemic leukocyte-endothelial adherence by NO. Stroke 29:1423-1429.
7. 15N) nitrite in biological fluids. Anal. Biochem. 126:131-138.
8. Guruvayoorappan, C., Afira, A. H., Kuttan, G. (2006). Antioxidant potential of Biophytum sensitivum extract in vitro and in vivo. J. Basic. Clin. Physiol. Pharmacol. 17:255-267.
9. Guruvayoorappan, C., Kuttan, G. (2007a). Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression, endothelial cell migration, and capillary tube formation. J. Exp. Ther. Oncol. 6:241-250.
10. Guruvayoorappan, C., Kuttan, G. (2007b). Anti-metastatic effect of Biophytum sensitivum is exerted through its cytokine and immunomodulatory activity and its regulatory effect on the activation and nuclear translocation of transcription factors in B16F-10 melanoma cells. J. Exp. Ther. Oncol. (In press).
11. Guruvayoorappan, C., Kuttan, G. (2007c). Immunomodulatory and antitumor activity of Biophytum sensitivum extract. Asian Pacafic J. Cancer Prev. 8:27-32.
12. Heiss, E., Herhaus, C., Klimo, K., Bartsch, H., Gerhauser, C. (2001). Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276:32008-32015.
13. Isomaki, P., Punnonen, J. (1997). Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann. Med. 29:499-507.
14. Jachak, S. M., Bucar, F., Kartnig, J. (1994). Anti-inflammatory activity of extracts of Biophytum sensitivum in carrageenan induced paw edema. Phytother. Res. 13:73-74.
15. Jirovetz, L., Buchbauer, G., Wobus, A., Shafi, M. P., Jose, B., (2004). Medicinally used plants from India: analysis of the essential oil of air-dried Biophytum sensitivum (L.) DC. Sci. Pharm. 72:87-96.
16. Jorens, P. G., Van Overveld, F. J., Bult, H., Vermeire, P. A., Herman, A. G. (1991). L[small cap]-arginine dependent production of nitrogen oxides by rat pulmonary macrophages. Eur. J. Pharmacol. 200:205-209.
17. Kim, K. M., Kwon, Y. G., Chung, H. T., Yun, Y. G., Pae, H. O., Han, J. A., Ha, K. S., Kim, T. W., Kim, Y. M. (2003). Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-κB activation. Toxicol. Appl. Pharmacol. 190:1-8.
18. Laskin, D. L., Pendino, K. J. (1995). Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35:655-677.
19. Libby, P., Ridker, P. M., Maseri, A. (2000). Inflammation and atherosclerosis. Circulation 105:1135-1143.
20. Lin, Y. L., Wang, W. Y. (2003). Chemical constituents of Biophytum sensitivum. Chin. Pharm. 55:71-75.
21. Lowenstein, C. J., Hill, S. L., Lafond-Walker, A., Wu, J., Allen, G., Landavere, M., Rose, N. R., Herskowitz, A. (1996). NO inhibits viral replication in murine myocarditis. J. Clin. Invest. 97:1837-1843.
22. Ma, Q., Kinneer, K. (2002). Chemoprotection by phenolic antioxidants: inhibition of tumor necrosis factor-alpha induction in macrophages. J. Biol. Chem. 277:2477-2484.
23. Martin, E., Nathan, C., Xie, Q. (1994). Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180:977-984.
24. Moilanen, E., Vapaatalo, H. (1995). Nitric oxide in inflammation and immune response. Ann. Med. 27:359-367.
25. Mojena, M., Hortelano, S., Castrillo, A., Diaz-Guerra, M. J., Garcia-Barchino, M. J., Saez, G. T., Bosca, L. (2001). Protection by nitric oxide against liver inflammatory injury in animals carrying a nitic oxide synthase-2 transgene. FASEB J. 15:583-585.
26. Nathan, C. F., Gabay, J. (1992). Antimicrobial mechanisms of macrophages. InVan Furtin, R. (ed.), Mononuclear Phagocytes. Biology of Monocytes and Macrophages. Boston/London: Kluwer, Dordrecht, pp. 259-267.
27. Nussler, A. K., Billiar, T. R. (1993). Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukocyte Biol. 54:171-178.
28. Palmer, R. M. J., Ashton, D. S., Moncada, S. (1988). Vascular endothelial cells synthesize NO from L[small cap]-arginine. Nature 333:664-666.
29. Pradeep. C. R., Kuttan., G. (2003). Effect of Piperine on the inhibition of nitric oxide (NO) and TNF-α production. Immunopharmacol. Immunotoxicol. 25:337-346.
30. Puri, D. (2001). The insulinotropic activity of the Nepalese medicinal plant Biophytum sensitivum: preliminary experimental study. J. Ethnopharmacol. 78:89-93.
31. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., Isakson, P. (1994). Pharmacological and biochemical demonstration of the role of cyclo-oxygenase-2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A. 91:12013-12017.
32. Shapira, L., Soskolne, W. A., Houri, Y., Barak, V., Halabi, A., Stabholz, A. (1996). Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect. Immun. 64:825-828.
33. Stoclet, J. C., Muller, B., Andriantsitohaina, R., Kleschyor, A. (1998). Overexpression of NO in pathophysiology of blood vessels. Biochemistry 63:826-832.
34. Suh, N., Honda, T., Finlay, H. J., Barchowsky, A., Williams, C., Benoit, W. E., Xie, Q. W., Nathan, C., Gribble, G. W., Sporn, M. B. (1998). Novel triterpenoids suppress inducible NO synthase (iNOS) and inducible cyclooxygenase (cyclooxygenase-2) in mouse macrophages. Cancer Res. 58:717-723.
35. ter Steege, J. C. A., van de Ven, M. W. C. M., Forget, P. Ph., Brouckaert, P., Buurman, W. A. (1998). The role of endogenous IFN-γ, TNF-α, and IL-10 in LPS-induced nitric oxide release in mouse model. Cytokine 10:115-123.
36. Thejass, P., Kuttan, G. (2007). Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumor-specific angiogenesis by downregulating nitric oxide (NO) and tumor necrosis factor-α (TNF-α) production. Nitric Oxide 16:247-257.
37. Tiao, G., Rafferty, J., Ogle, C., Fischer, J. E., Hasselgren, P. O. (1994). Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery 116:332-338.
38. Tomkins, P., Cooper, K., Webber, D., Bower, G. (1992). The L929 cell bioassay for murine tumor necrosis factor is not influenced by other cytokines. J. Immunol. Meth. 151:313-315.
39. Vallance, P., Moncada, S. (1993). Role of endogenous nitric oxide in septic shock. New Horizons 1:77-86.
40. Worall, N. K., Lazenby, W. D., Misko, T. P., Lin, T. S., Rodi, C. P., Manning, P. T., Tilton, R. G., Williamson, J. R., Ferguson, T. B., Jr. (1995). Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 181:63-70.